Hybrid Solutions (UPS)

Hybrid Solutions (UPS)

Market Access

Information

As a subsidiary of UPS, Marken’s hybrid solutions are unlike any other in the industry. With global coverage across every region, Marken has the capability to provide end-to-end oversight and flexibility, allowing more time for investigator sites to prepare and package samples and alleviate the pressure of focusing on pick-up times. Learn how Marken’s unique solutions provide cost efficiency with greater flight options, higher quality to meet client demands and scalability to allow 100% control of the supply chain from origin to destination.
MarkenMarken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 56 locations worldwide for clinical trial material storage and distribution. Marken’s more than 1,300 staff members manage 85,000 drug and biological shipments every month at all temperature ranges in more than 220 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.

Log in